Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Thruvision Group PLC AGM Information 2024

Sep 19, 2024

7968_agm-r_2024-09-19_5bb99a15-c24f-4340-bf07-d236bb48643b.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9058E

Thruvision Group PLC

19 September 2024

19 September 2024

Thruvision Group plc

Result of Annual General Meeting

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology , announces that following the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed by the requisite majority. The number of proxies received in respect of each resolution were as follows:

Resolution Total votes for % Total votes against % Total votes cast Votes withheld
1. Receipt of directors and auditors report 130,323,945 99.99 10,040 0.01 130,333,985 18,005
2. Approval of remuneration report 118,210,281 90.70 12,122,285 9.30 130,332,566 19,424
3. Re-election of Tom Black 130,303,637 99.98 25,498 0.02 130,329,135 22,855
4. Re-election of Colin Evans 128,800,637 98.82 1,533,348 1.18 130,333,985 18,005
5. Re-election of Victoria Balchin 130,313,637 99.98 20,348 0.02 130,333,985 18,005
6. Re-election of Richard Amos 130,313,637 99.98 20,348 0.02 130,333,985 18,005
7. Re-election of Katrina Nurse 130,313,637 99.98 20,348 0.02 130,333,985 18,005
8. Re-appointment of Auditors 130,179,611 99.88 154,374 0.12 130,333,985 18,005
9. Authority for Directors to set Auditors remuneration 130,316,399 99.99 17,586 0.01 130,333,985 18,005
10. Authority for Directors to allot equity securities 130,313,637 99.99 15,498 0.01 130,329,135 22,855
11. Authority for Directors to allot equity securities for cash on a non-premptive basis 130,167,142 99.87 163,498 0.13 130,330,640 21,350
12. Authority for Directors to allot equity securities for cash in respect of an acquisition or other capital project. 130,167,142 99.87 171,998 0.13 130,339,140 12,850
13. Authority for the Company to make market purchases of its own Ordinary Shares 130,170,487 99.87 171,998 0.13 130,342,485 9,505

Notes

1.     Any proxy appointments which gave discretion to the Chairman have been included in the 'Total votes for' total.

2.     A 'Vote Withheld' is not a valid vote in law and was not counted in the calculation of the proportion of the votes 'for' or 'Against' a resolution. 

3.     All percentages have been rounded to two decimal places.

For further information please contact:

Thruvision Group plc                                     

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer
+44 (0)1235 425400
Investec Investment Banking (NOMAD & Broker)

James Rudd / Patrick Robb / Sebastian Lawrence
+44 (0)20 7597 5970

About Thruvision ( www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSFUFSUELSELU